Stanford medicine releases its research on Apple Heart watches
Category: #health  By Pankaj Singh  Date: 2019-11-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

Stanford medicine releases its research on Apple Heart watches
  • The study comprised enrollment of over 400,000 people, making it one of the biggest research efforts.
     
  • It also saw approximately 2,000 of people receiving notification of irregular pulse.

California-based Stanford Medicine recently came out with its long-awaited results from the Apple Heart Study, which represents one of the biggest research effort that depends on consumer application to get a good understanding about human health.

Reportedly, the study focused on how Apple Watch could act as a viable alternative to detect atrial fibrillation, a disorder that is often linked with a growing risk of stroke. Moreover, it comprised of more than 400,000 participants over eight months who owned an Apple Watch.

Apparently, Apple had sponsored the study and thereby owns the data which is still kept at Stanford. Moreover, the study’s methods and protocol were cleared in advance by the central institutional review board to safeguard the patient’s privacy.

Reliable reports claim that Atrial fibrillation commonly affects roughly 6 million citizens in the United States, with a majority of unaware of them having it. The disease could potentially be detected by employing algorithms and sensors. This has further made it a major target for makers of wearable devices.

Notably, Apple has integrated an electrocardiogram sensor in its Apple Watch Series 5 and Series 4 gadgets. These sensors allow the gadget to observe the rhythm of the heart and delivers health information quickly to its users.

Speaking on the move, Jeff Wessler, Cardiologist and Founder of the Heartbeat cardiology clinics, said that it is hard to identify atrial fibrillation in healthy people that are commonly in their mid-30s. Wessler has already begun to implement the patient’s data based on their Apple Watches and claims that diagnosis based on these devices will become a common trend in the future.

Source Credit: https://www.cnbc.com/2019/11/13/apple-releases-heart-study-results.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...